Global Infusion Market to Reach $5.5 B by 2017
November 21, 2011
Global Business Intelligence (GBI) Research recently released a development report on the infusion pump market. The organization is a market report provider performing studies on the current state of the global market. According to GBI, the number of patients diagnosed with chronic diseases such as cancer and diabetes is increasing.
GBI reported that advanced infusion systems with newer features and capabilities are gladly accepted by the market. Every year, the number of people diagnosed with diabetes, neurological diseases, cancer and obesity is considerably growing, and home-care treatments are being preferred. The demand for cost-effective home-care facilities, including infusion pump systems, is increasing.
The US continues to be the top region with the largest revenue of infusion pump systems over the past years. However, fast growing economies including Asia, Latin America, Eastern Europe and Middle East are expected to leap with 7.7% Compound Annual Growth Rate (CAGR) over the analysis period. The market for infusion pumps is expected to reach US $5.5 billion in the next six years.
GBI conducted the market research with key profiles of competitive manufacturers including Animas Corporation, Baxa Corporation, Baxter Healthcare Corporation, B. Braun Melsungen AG, CareFusion Corporation, Codman & Shurtleff Inc., DJO Incorporated, Excelsior Medical, Hospira Inc., I-Flow Corporation, Insulet Corporation, LMA International, Medronic Inc., Moog Inc., Curlin Medical Inc., Nipro Medical Corporation, Roche Holdings AG, Smiths Medical and Stryker Instruments.
AIV offers parts and repair services for most leading infusion pump systems in the market. For more information on products and services for infusion pumps available, visit http://www.aiv-inc.com/iv-infusion-pump-replacement-parts.html.
